Transplant Diagnostic Market Forecast Report, 2018-2026
Transplant Diagnostic Market – Snapshot
The global transplant diagnostic market is expanding due to the increasing number of patients emphasizing on early patient profiling during organ transplantation and rising adoption of transplant diagnostic techniques. The global transplant diagnostic market was valued at US$ 730.9 Mn in 2017 and is projected to surpass US$ 1,289.3 Mn by 2026, expanding at a compound annual growth rate (CAGR) of more than 6.5% from 2018 to 2026. The global market is expanding at a relatively higher growth rate owing to increasing bone marrow transplantation practices, high incidences of pediatric transplantation surgery, occurrence of kidney disorder among geriatric population, and increasing clinical evidence to establish clinical efficacy of molecular assay technique.
Transplant diagnostic is an administrative as well as clinical tool that helps improve operational efficiency of transplantation technique. Transplant diagnostic aids the patients suffering from cancer in order to improve overall operational efficiency as well as patient care. High prevalence and incidence rates of kidney dysfunction, cardiac diseases, increase in number of cases of lungs disorder and orthopedic injuries in the global population has led to the increase in patient flow to private clinics and hospitals. These factors, collectively, are projected to drive the demand for transplant diagnostic in the near future. Furthermore, the compatibility of markers increases the probability of graft survival and decreases severe immunologic transplant complications, which in turn is estimated to fuel the transplant diagnostic market in the near future.
The global transplant diagnostic market has been broadly segmented based on screening, technique, product & services, application, end-user, and region. In terms of application, the global market has been categorized into stem cell transplantation and solid organ transplantation. The solid organ transplantation segment has been further sub-segmented into kidney, liver, heart, lungs, pancreas, and small bowel. The kidney transplant sub-segment accounted for a key share of the solid organ transplantation segment, in terms of revenue, of the global market in 2017. The liver sub-segment is estimated to expand at a prominent growth rate during the forecast period, and the sub-segment is estimated to report significant gain in market share by the end of 2026. Liver transplant diagnostic is increasingly gaining popularity among cancer patients and physicians, which is also a major factor that is estimated to drive the liver sub-segment between 2018 and 2026.
In terms of technique, the global transplant diagnostic has been classified into molecular assay and non-molecular assay. The non-molecular assay segment dominated the global market and is likely to maintain its dominance by the end of 2026 with marginal increase in its year-on-year growth rate. Rapid advances in the fields of transplant medicine and cancer treatment and the ever-growing implementation of immunomodulatory regimens led to significant increase in the prevalence and prolonged survival of people in immunocompromised states. These are key factors which have led the non-molecular assay segment to hold a prominent share of the global market. Based on screening, the transplant diagnostic market has been bifurcated into pre-transplant diagnostic and post-transplant diagnostic. In terms of product & services, the transplant diagnostic market has been split into reagents & consumables, instruments, and software. Based on end-user, the global market has been segregated into hospital & transplant centers, research laboratories, and others.
In terms of region, the global transplant diagnostic market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2026. The market in North America is primarily driven by the rapid increase in geriatric population, high adoption rate of transplantation technique for cancer, and rise in incidence of kidney disorders among geriatric population in the U.S. Moreover, increasing awareness programs about transplantation by pharmaceutical companies is a major practice witnessed in the U.S., which is projected to fuel the transplant diagnostic market in the U.S. during the forecast period. The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. China dominated the transplant diagnostic market in Asia Pacific, whereas the market in India is estimated to expand at a significant CAGR during the forecast period.
Companies such as Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., and Becton, Dickinson and Company accounted for a major share of the global transplant diagnostic market in 2017 In July 2017, Thermo Fisher Scientific acquired Linkage Biosciences. Linkage Biosciences is presently a part of Thermo Fisher's transplant diagnostics business. Through this acquisition, Thermo Fisher currently provides services to more than 1,000 transplant centres in more than 60 countries. Other global players operating in the market include Ortho Clinical Diagnostics (a part of Carlyle Group), Immucor, Inc., Illumina, Inc., Siemens Healthineers (Siemens AG), and Agilent Technologies. Companies are adopting the strategy of acquisition and collaboration with parallel companies in order to improve and strengthen its geographic presence in the global market.
The global transplant diagnostic market has been segmented as given below:
|
Screening |
|
|
Technique |
|
|
Application |
|
|
Product & Services |
|
|
End-user |
|
|
Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Transplant Diagnostic Market
4. Market Overview
4.1. Introduction
4.1.1. Technique Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.3.4. Trends
4.4. Global Transplant Diagnostic Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Market Outlook
4.6.Regulatory Scenarios
4.7. Number of Transplantations, by Region/Country
4.8. Key Success Factors of Top 3 Companies
5. Global Transplant Diagnostic Market Analysis and Forecast, by Technique
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Global Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
5.3.1. Molecular Assay
5.3.2. Non-Molecular Assay
5.4. Market Attractiveness, by Technique
6. Global Transplant Diagnostic Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
6.3.1. Solid Organ Transplantation
6.3.1.1. Kidney
6.3.1.2. Liver
6.3.1.3. Heart
6.3.1.4. Lungs
6.3.1.5. Pancreas
6.3.1.6. Small Bowel
6.3.2. Stem Cell Transplantation
6.4. Market Attractiveness, by Application
7. Global Transplant Diagnostic Market Analysis and Forecast, by Screening
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
7.3.1. Pre-Transplant Diagnostic
7.3.2. Post-Transplant Diagnostic
7.3.3. Instruments
7.4. Market Attractiveness, by Screening
8. Global Transplant Diagnostic Market Analysis and Forecast, by Product & Services
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
8.3.1. Reagents & Consumables
8.3.2. Instruments
8.3.3. Software & Services
8.4. Market Attractiveness, by Product & Services
9. Global Transplant Diagnostic Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospital & Transplant Centers
9.3.2. Research Laboratories
9.3.3. Others
9.4. Market Attractiveness, by End-user
10. Global Transplant Diagnostic Market Analysis and Forecast, by Region
10.1.Key Findings
10.2. Global Transplant Diagnostic Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3.Market Attractiveness, by Country/Region
11. North America Transplant Diagnostic Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. North America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
11.2.1. Molecular Assay
11.2.2. Non-Molecular Assay
11.3. North America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
11.3.1. Solid Organ Transplantation
11.3.1.1. Kidney
11.3.1.2. Liver
11.3.1.3. Heart
11.3.1.4. Lungs
11.3.1.5. Pancreas
11.3.1.6. Small Bowel
11.3.2. Stem Cell Transplantation
11.4. North America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
11.4.1. Pre-Transplant Diagnostic
11.4.2. Post-Transplant Diagnostic
11.4.3. Instruments
11.5. North America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
11.5.1. Reagents & Consumables
11.5.2. Instruments
11.5.3. Software & Services
11.6. North America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
11.6.1. Hospital & Transplant Centers
11.6.2. Research Laboratories
11.6.3. Others
11.7. North America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
11.7.1. U.S.
11.7.2. Canada
11.8. North America Transplant Diagnostic Market Attractiveness Analysis
11.8.1. By Technique
11.8.2. By Application
11.8.3. By Screening
11.8.4. By Product & Services
11.8.5. By End-user
11.8.6. By Country
12. Europe Transplant Diagnostic Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Europe Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
12.2.1. Molecular Assay
12.2.2. Non-Molecular Assay
12.3. Europe Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
12.3.1. Solid Organ Transplantation
12.3.1.1. Kidney
12.3.1.2. Liver
12.3.1.3. Heart
12.3.1.4. Lungs
12.3.1.5. Pancreas
12.3.1.6. Small Bowel
12.3.2. Stem Cell Transplantation
12.4. Europe Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
12.4.1. Pre-Transplant Diagnostic
12.4.2. Post-Transplant Diagnostic
12.4.3. Instruments
12.5. Europe Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
12.5.1. Reagents & Consumables
12.5.2. Instruments
12.5.3. Software & Services
12.6. Europe Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
12.6.1. Hospital & Transplant Centers
12.6.2. Research Laboratories
12.6.3. Others
12.7. Europe Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
12.7.1. Germany
12.7.2. U.K.
12.7.3. France
12.7.4. Spain
12.7.5. Italy
12.7.6. Rest of Europe
12.8. Europe Transplant Diagnostic Market Attractiveness Analysis
12.8.1. By Technique
12.8.2. By Application
12.8.3. By Screening
12.8.4. By Product & Services
12.8.5. By End-user
12.8.6. By Country
13. Asia Pacific Transplant Diagnostic Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Asia Pacific Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
13.2.1. Molecular Assay
13.2.2. Non-Molecular Assay
13.3. Asia Pacific Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
13.3.1. Solid Organ Transplantation
13.3.1.1. Kidney
13.3.1.2. Liver
13.3.1.3. Heart
13.3.1.4. Lungs
13.3.1.5. Pancreas
13.3.1.6. Small Bowel
13.3.2. Stem Cell Transplantation
13.4. Asia Pacific Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
13.4.1. Pre-Transplant Diagnostic
13.4.2. Post-Transplant Diagnostic
13.4.3. Instruments
13.5. Asia Pacific Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
13.5.1. Reagents & Consumables
13.5.2. Instruments
13.5.3. Software & Services
13.6. Asia Pacific Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
13.6.1. Hospital & Transplant Centers
13.6.2. Research Laboratories
13.6.3. Others
13.7. Asia Pacific Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
13.7.1. China
13.7.2. Japan
13.7.3. India
13.7.4. Australia & New Zealand
13.7.5. Rest of Asia Pacific
13.8. Asia Pacific Transplant Diagnostic Market Attractiveness Analysis
13.8.1. By Technique
13.8.2. By Application
13.8.3. By Screening
13.8.4. By Product & Services
13.8.5. By End-user
13.8.6. By Country
14. Latin America Transplant Diagnostic Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2. Latin America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
14.2.1. Molecular Assay
14.2.2. Non-Molecular Assay
14.3. Latin America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
14.3.1. Solid Organ Transplantation
14.3.1.1. Kidney
14.3.1.2. Liver
14.3.1.3. Heart
14.3.1.4. Lungs
14.3.1.5. Pancreas
14.3.1.6. Small Bowel
14.3.2. Stem Cell Transplantation
14.4. Latin America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
14.4.1. Pre-Transplant Diagnostic
14.4.2. Post-Transplant Diagnostic
14.4.3. Instruments
14.5. Latin America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
14.5.1. Reagents & Consumables
14.5.2. Instruments
14.5.3. Software & Services
14.6. Latin America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
14.6.1. Hospital & Transplant Centers
14.6.2. Research Laboratories
14.6.3. Others
14.7. Latin America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
14.7.1. Brazil
14.7.2. Mexico
14.7.3. Rest of Latin America
14.8. Latin America Transplant Diagnostic Market Attractiveness Analysis
14.8.1. By Technique
14.8.2. By Application
14.8.3. By Screening
14.8.4. By Product & Services
14.8.5. By End-user
14.8.6. By Country
15. Middle East & Africa Transplant Diagnostic Market Analysis and Forecast
15.1.Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
15.2.1. Molecular Assay
15.2.2. Non-Molecular Assay
15.3. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
15.3.1. Solid Organ Transplantation
15.3.1.1. Kidney
15.3.1.2. Liver
15.3.1.3. Heart
15.3.1.4. Lungs
15.3.1.5. Pancreas
15.3.1.6. Small Bowel
15.3.2. Stem Cell Transplantation
15.4. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
15.4.1. Pre-Transplant Diagnostic
15.4.2. Post-Transplant Diagnostic
15.4.3. Instruments
15.5. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
15.5.1. Reagents & Consumables
15.5.2. Instruments
15.5.3. Software & Services
15.6. Middle East & Africa Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
15.6.1. Hospital & Transplant Centers
15.6.2. Research Laboratories
15.6.3. Others
15.7. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
15.7.1. GCC countries
15.7.2. South Africa
15.7.3. Israel
15.7.4. Rest of Middle East & Africa
15.8. Middle East & Africa Transplant Diagnostic Market Attractiveness Analysis
15.8.1. By Technique
15.8.2. By Application
15.8.3. By Screening
15.8.4. By Product & Services
15.8.5. By End-user
15.8.6. By Country
16. Competition Landscape
16.1.Market Player – Competition Matrix (by Tier and Size of companies)
16.2.Market Share Analysis by Company (2017)
16.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
16.3.1. Bio-Rad Laboratories, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Financial Overview
16.3.1.5. Strategic Overview
16.3.2. Qiagen N.V.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Financial Overview
16.3.2.5. Strategic Overview
16.3.3. F. Hoffmann-La Roche AG
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Financial Overview
16.3.3.5. Strategic Overview
16.3.4. Thermo Fisher Scientific, Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Financial Overview
16.3.4.5. Strategic Overview
16.3.5. Becton, Dickinson and Company
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Financial Overview
16.3.5.5. Strategic Overview
16.3.6. Ortho Clinical Diagnostics
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Financial Overview
16.3.6.5. Strategic Overview
16.3.7. Immucor, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Financial Overview
16.3.7.5. Strategic Overview
16.3.8. Illumina, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Financial Overview
16.3.8.5. Strategic Overview
16.3.9. Siemens Healthineers (Siemens AG)
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Financial Overview
16.3.9.5. Strategic Overview
16.3.10. Agilent Technologies
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Financial Overview
16.3.10.5. Strategic Overview
16.3.11. Others
List of Tables
Table 01: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 02: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 03: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 05: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 06: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 07: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 08: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 09: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 10: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 11: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 12: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 13: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 14: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 15: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 16: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 17: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 18: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 19: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 20: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 21: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 22: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 23: Europe Animal Parasiticides Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 24: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 25: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 26: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 27: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 28: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 29: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 30: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 31: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 32: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 33: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 34: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 35: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 36: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 37: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 38: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 39: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 40: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 41: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 42: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 43: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 44: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 45: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 46: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 47: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 48: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 49: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 50: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 51: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 52: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 53: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 54: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 55: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 56: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 57: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 58: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 59: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 60: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 61: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 62: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 63: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 64: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 65: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 66: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 67: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 68: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 69: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 70: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 71: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 72: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 73: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 74: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 75: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 76: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 77: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 78: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 79: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 80: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 81: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 82: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 83: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 84: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 85: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 86: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 87: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 88: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 89: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 90: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 91: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 92: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 93: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 94: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 95: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 96: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 97: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 98: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 99: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 100: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 101: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 102: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 103: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 104: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 105: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 106: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 107: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 108: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 109: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 110: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 111: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 112: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 113: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 114: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 115: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 116: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 117: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
Table 118: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
Table 119: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 120: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
Table 121: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
Table 122: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
List of Figures
Figure 01: Global Transplant Diagnostic Market Size (US$ Mn) Forecast, 2016–2026
Figure 02: Global Transplant Diagnostic Market Value Share, by Screening, 2017
Figure 03: Global Transplant Diagnostic Market Value Share, by Application, 2017
Figure 04: Global Transplant Diagnostic Market Value Share, by Technique, 2017
Figure 05: Global Transplant Diagnostic Market Value Share, by End-user, 2017
Figure 06: Global Transplant Diagnostic Market Value Share, by Product & Services, 2017
Figure 07: Global Transplant Diagnostic Market Value Share, by Region, 2017
Figure 08: Global Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 09: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pre-Transplant Diagnostic, 2017–2026
Figure 10: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Post-Transplant Diagnostic, 2017–2026
Figure 11: Global Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 12: Global Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 13: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Molecular Assay, 2017–2026
Figure 14: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-Molecular Assay, 2017–2026
Figure 15: Global Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 16: Global Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 17: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stem Cell Transplantation, 2017–2026
Figure 18: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Solid Organ Transplantation, 2017–2026
Figure 19: Global Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 20: Global Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 21: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Reagents & Consumables, 2017–2026
Figure 22: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Software & Services, 2017–2026
Figure 23: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2017–2026
Figure 24: Global Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 25: Global Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 26: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital & Transplant Centers, 2017–2026
Figure 27: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2026
Figure 28: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research Laboratories, 2017–2026
Figure 29: Global Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Figure 30: Global Transplant Diagnostic Market Value Share, by Region, 2018 and 2025
Figure 31: Global Transplant Diagnostic Market Attractiveness, by Region, 2018–2026
Figure 32: North America Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 33: North America Transplant Diagnostic Market Value Share, by Country, 2018–2026
Figure 34: North America Transplant Diagnostic Market Attractiveness, by Country, 2018–2026
Figure 35: North America Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 36: North America Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 37: North America Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 38: North America Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 39: North America Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 40: North America Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 41: North America Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 42: North America Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 43: North America Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 44: North America Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Figure 45: Europe Animal Parasiticides Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 46: Europe Animal Parasiticides Market Value Share, by Country/Sub-region, 2018–2026
Figure 47: Europe Animal Parasiticides Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 48: Europe Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 49: Europe Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 50: Europe Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 51: Europe Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 52: Europe Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 53: Europe Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 54: Europe Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 55: Europe Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 56: Europe Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 57: Europe Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Figure 58: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016?2026
Figure 59: Latin America Transplant Diagnostic Market Value Share, by Country/Sub-region, 2018–2026
Figure 60: Latin America Transplant Diagnostic Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 61: Latin America Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 62: Latin America Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 63: Latin America Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 64: Latin America Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 65: Latin America Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 66: Latin America Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 67: Latin America Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 68: Latin America Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 69: Latin America Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 70: Latin America Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Figure 71: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 72: MEA Transplant Diagnostic Market Value Share, by Country/Sub-region, 2018–2026
Figure 73: MEA Transplant Diagnostic Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 74: MEA Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
Figure 75: MEA Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
Figure 76: MEA Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
Figure 77: MEA Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
Figure 78: MEA Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
Figure 79: MEA Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
Figure 80: MEA Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
Figure 81: MEA Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
Figure 82: MEA Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
Figure 83: MEA Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes